All questions
Guidelines: Paxlovid (nirmatrelvir; ritonavir) in COVID-19 1 question · 1 source
Questions that apply to every indication of Paxlovid are on Paxlovid (nirmatrelvir; ritonavir), all indications .
Guidelines Paxlovid: which conditions raise the risk of severe COVID-19 (CDC list)? “Age (50+ years)
Age is the strongest risk factor for progressing to severe COVID-19.2
Vaccination status
People who are unvaccinated or not up to date on their COVID-19 vaccinations are at an increased risk of severe COVID-19.2
Underlying medical conditions that increase the risk of severe COVID-19 include2 :
Diabetes
Heart conditions
Smoking, current or former
Obesity
Disabilities, including learning disabilities
Certain racial and/or ethnic minority groups are at increased risk of severe outcomes due to inequities in healthcare and socioeconomic factors.2
Underlying medical conditions and factors associated with higher risk for severe COVID-192
Higher risk (conclusive evidence)
Asthma
Cancer
Hematologic malignancies
Cerebrovascular disease
Chronic kidney disease*
People receiving dialysis†
Chronic lung diseases, limited to:
Bronchiectasis
COPD (chronic obstructive pulmonary disease)
Interstitial lung disease
Pulmonary embolism
Pulmonary hypertension
Chronic liver diseases, limited to:
Cirrhosis
Nonalcoholic fatty liver disease
Alcoholic liver disease
Autoimmune hepatitis
Cystic fibrosis
Diabetes mellitus type 1
Diabetes mellitus type 2*
Disabilities, including Down syndrome
Heart conditions (such as heart failure, coronary artery disease, or cardiomyopathies)
HIV
Mental health conditions, limited to:
Mood disorders, including depression
Schizophrenia spectrum disorders
Neurologic conditions limited to dementia and Parkinson's disease
Obesity (BMI ≥30 kg/m2 or ≥95th percentile in children)
Physical inactivity
Pregnancy and recent pregnancy
Primary immunodeficiencies
Smoking, current and former
Solid organ or blood stem cell transplantation
Tuberculosis
Use of corticosteroids or other immunosuppressive medications
Suggestive higher risk‡
Epilepsy
Hemophilia
Overweight (BMI ≥25 kg/m2 , but <30 kg/m2 )
Sickle cell disease
Substance use disorders
Mixed evidence (inconclusive: no conclusions can be drawn from the evidence)
Alpha-1 antitrypsin deficiency
Bronchopulmonary dysplasia
Hepatitis B and C
Hypertension*
Thalassemia” (opens the source at this quote in a new tab) Copy Flag
Note: This list is Centers for Disease Control and Prevention guidance as reproduced on the High-Risk Factors page of the Paxlovid HCP site, which cites the CDC page "Underlying conditions and the higher risk for severe COVID-19" as accessed March 6, 2026. The FAQ page of the same site prints the list without Parkinson's disease, epilepsy, and hemophilia. The EPIC-HR trial used its own risk-factor criteria.